References
- Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature. 2012;483(7391):531–10. PMID: 22460880. doi:https://doi.org/10.1038/483531a.
- Voskuil J. Commercial antibodies and their validation. F1000Res. 2014;3:232. PMID: 25324967. doi:https://doi.org/10.12688/f1000research.4966.2.
- Helsby MA, Fenn JR, Chalmers AD. Reporting research antibody use: how to increase experimental reproducibility. F1000Res. 2013;2:153. PMID: 24358895. doi:https://doi.org/10.12688/f1000research.2-153.v2.
- Baker M. Reproducibility crisis: blame it on the antibodies. Nature. 2015;521(7552):274–76. PMID: 25993940. doi:https://doi.org/10.1038/521274a.
- Baker M. Antibody anarchy: A call to order. Nature. 2015;527(7579):545–51. PMID: 26607547. doi:https://doi.org/10.1038/527545a.
- Weller MG. Quality issues of research antibodies. Anal Chem Insights. 2016;11:21–27. PMID: 27013861. doi:https://doi.org/10.4137/ACI.S31614.
- Roncador G, Engel P, Maestre L, Anderson AP, Cordell JL, Cragg MS, Šerbec VČ, Jones M, Lisnic VJ, Kremer L, et al. The European antibody network’s practical guide to finding and validating suitable antibodies for research. MAbs. 2016;8(1):27–36. PMID: 26418356. doi:https://doi.org/10.1080/19420862.2015.1100787.
- Rizner TL, Sasano H, Choi MH, Odermatt A, Adamski J. Recommendations for description and validation of antibodies for research use. J Steroid Biochem Mol Biol. 2016;156:40–42. PMID: 26655410. doi:https://doi.org/10.1016/j.jsbmb.2015.11.021.
- Uhlén M, Bandrowski A, Carr S, Edwards A, Ellenberg J, Lundberg E, Rimm DL, Rodriguez H, Hiltke T, Snyder M, et al. A proposal for antibody validation. Nat Methods. 2016;13(10):823–27. PMID: 27595404. doi:https://doi.org/10.1038/nmeth.3995.
- Freedman LP Global biological standards institute: asilomar antibody workshop report 2016. https://www.gbsi.org/gbsi-content/uploads/2016/12/Workshop-Report_12-15-2016.pdf
- Taussig MJ, Fonseca C, Trimmer JS. Antibody validation: a view from the mountains. N Biotechnol. 2018;45:1–8. PMID: 30086383. doi:https://doi.org/10.1016/j.nbt.2018.08.002.
- Goodman SL. The 3rd antibody validation meeting: bath UK 20-21st September 2018. F1000Res. 2018;7:1989. PMID: 30647913. doi:https://doi.org/10.12688/f1000research.17645.1.
- Bradbury A, Plückthun A. Reproducibility: standardize antibodies used in research. Nature. 2015;518(7537):27–29. PMID: 25652980. doi:https://doi.org/10.1038/518027a.
- Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 2015;13(6):e1002165. eCollection 2015 Jun. Erratum in: PLoS Biol. 2018 Apr 10;16(4):e1002626.PMID: 26057340. doi:https://doi.org/10.1371/journal.pbio.1002165.
- Grand View Research. Research antibodies market size, share & trends analysis report by type (Monoclonal, Polyclonal), by end use, by product, by technology, by source, by application (Oncology, Stem Cells), and segment forecasts, 2020-2027 [PDF]. San Francisco (USA): GVR Inc.; 2020 [updated 2020 Feb. Market research report on commercial antibodies]. Report ID: GVR-2-68038-124-5. https://www.grandviewresearch.com/industry-analysis/research-antibodies-market.
- Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood. 2006;107(5):1892–95. PMID: 16249375. doi:https://doi.org/10.1182/blood-2005-10-4066.
- Andersson S, Sundberg M, Pristovsek N, Ibrahim A, Jonsson P, Katona B, Clausson CM, Zieba A, Ramström M, Söderberg O, et al. Insufficient antibody validation challenges oestrogen receptor beta research. Nat Commun. 2017;8:15840. PMID: 28643774. doi:https://doi.org/10.1038/ncomms15840.
- Schrohl AS, Pedersen HC, Jensen SS, Nielsen SL, Brünner N. Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies. Histopathology. 2011;59(5):975–83. PMID: 22092409. doi:https://doi.org/10.1111/j.1365-2559.2011.04034.x.
- Vaezi AE, Bepler G, Bhagwat NR, Malysa A, Rubatt JM, Chen W, Hood BL, Conrads TP, Wang L, Kemp CE, et al. Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas. Cancer. 2014;120(12):1898–907. PMID: 24692084. doi:https://doi.org/10.1002/cncr.28643.
- Lukinavičius G, Lavogina D, Gönczy P, Johnsson K. Commercial Cdk1 antibodies recognize the centrosomal protein Cep152. Biotechniques. 2013;55(3):111–14. PMID: 24137814. doi:https://doi.org/10.2144/000114074.
- Sikorski K, Mehta A, Inngjerdingen M, Thakor F, Kling S, Kalina T, Nyman TA, Stensland ME, Zhou W, de Souza GA, et al. A high-throughput pipeline for validation of antibodies. Nat Methods. 2018;15(11):909–12. PMID: 30377371. doi:https://doi.org/10.1038/s41592-018-0179-8.
- de la Rosa Carrillo D, Sikorski K, Khnykin D, Wu W, Lund-Johansen F. High-resolution antibody array analysis of proteins from primary human keratinocytes and leukocytes. PLoS One. 2018;13(12):e0209271. PMID: 30589857. doi:https://doi.org/10.1371/journal.pone.0209271.
- Bradbury ARM, Trinklein ND, Thie H, Wilkinson IC, Tandon AK, Anderson S, Bladen CL, Jones B, Aldred SF, Bestagno M, et al. When monoclonal antibodies are not monospecific: hybridomas frequently express additional functional variable regions. MAbs. 2018;10(4):539–46. PMID: 29485921. doi:https://doi.org/10.1080/19420862.2018.1445456.
- Menke J, Roelandse M, Ozyurt B, Martone M, Bandrowski A. Rigor and Transparency Index, a new metric of quality for assessing biological and medical science methods. bioRxiv. preprint posted January 18, 2020, available under a CC-BY 4.0 International license. doi:https://doi.org/10.1101/2020.01.15.908111.
- Voskuil JL. The challenges with the validation of research antibodies. F1000Res. 2017;6:161. PMID: 28357047. doi:https://doi.org/10.12688/f1000research.10851.1.
- Vasilevsky NA, Brush MH, Paddock H, Ponting L, Tripathy SJ, Larocca GM, Haendel MA. On the reproducibility of science: unique identification of research resources in the biomedical literature. PeerJ. 2013;1:e148. PMID: 24032093. doi:https://doi.org/10.7717/peerj.148.
- Bandrowski AE, Martone ME. RRIDs: a simple step toward improving reproducibility through rigor and transparency of experimental methods. Neuron. 2016;90(3):434–36. PMID: 27151636. doi:https://doi.org/10.1016/j.neuron.2016.04.030.
- Helsby MA, Leader PM, Fenn JR, Gulsen T, Bryant C, Doughton G, Sharpe B, Whitley P, Caunt CJ, James K, et al. CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited. BMC Cell Biol. 2014;15:6. PMID: 24528853. doi:https://doi.org/10.1186/1471-2121-15-6.
- Ghosh R, Gilda JE, Gomes AV. The necessity of and strategies for improving confidence in the accuracy of western blots. Expert Rev Proteomics. 2014;11(5):549–60. PMID: 25059473. doi:https://doi.org/10.1586/14789450.2014.939635.
- Gilda JE, Ghosh R, Cheah JX, West TM, Bodine SC, Gomes AV. Western blotting inaccuracies with unverified antibodies: need for a western blotting minimal reporting standard (WBMRS). PLoS One. 2015;10(8):e0135392. PMID: 26287535. doi:https://doi.org/10.1371/journal.pone.0135392.
- Venkataraman A, Yang K, Irizarry J, Mackiewicz M, Mita P, Kuang Z, Xue L, Ghosh D, Liu S, Ramos P, et al. A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors. Nat Methods. 2018;15(5):330–38. PMID: 29638227. doi:https://doi.org/10.1038/nmeth.4632.
- Frenzel A, Hust M, Schirrmann T. Expression of recombinant antibodies. Front Immunol. 2013;4:217. PMID: 23908655. doi:https://doi.org/10.3389/fimmu.2013.00217.
- Owens B. Faster, deeper, smaller-the rise of antibody-like scaffolds. Nat Biotechnol. 2017;35(7):602–03. PMID: 28700554. doi:https://doi.org/10.1038/nbt0717-602.
- Plückthun A. Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy. Annu Rev Pharmacol Toxicol. 2015;55:489–511. PMID: 25562645. doi:https://doi.org/10.1146/annurev-pharmtox-010611-134654.
- Joshi A, Mayr M. In aptamers they trust: the caveats of the SOMAscan biomarker discovery platform from somalogic. Circulation. 2018;138(22):2482–85. PMID: 30524136. doi:https://doi.org/10.1161/CIRCULATIONAHA.118.036823.